Cited by 1,888Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsCardiovascular Function and Risk Factors

Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death

Open access
Gami, Apoor S., Witt, Brandi J., Howard, Daniel E., Erwin, Patricia J., Gami, Lisa A., Somers, Virend K., Montori, Victor M.·2007·Journal of the American College of Cardiology

Abstract

Objectives The purpose of this research was to assess the association between the metabolic syndrome (MetSyn) and cardiovascular events and mortality by meta-analyses of longitudinal studies.Background Controversy exists regarding the cardiovascular risk associated with MetSyn.Methods We searched electronic reference databases through March 2005, studies that referenced Reaven's seminal article, abstracts presented at meetings in 2003 to 2004, and queried experts. Two reviewers independently assessed eligibility. Longitudinal studies reporting associations between MetSyn and cardiovascular events or mortality were eligible. Two reviewers independently used a standardized form to collect data from published reports. Authors were contacted. Study quality was assessed by the control of selection, detection, and attrition biases.Results We found 37 eligible studies that included 43 cohorts (inception 1971 to 1997) and 172,573 individuals. Random effects meta-analyses showed MetSyn had a relative risk (RR) of cardiovascular events and death of 1.78 (95% confidence interval [CI] 1.58 to 2.00). The association was stronger in women (RR 2.63 vs. 1.98, p = 0.09), in studies enrolling lower risk (<10%) individuals (RR 1.96 vs. 1.43, p = 0.04), and in studies using factor analysis or the World Health Organization definition (RR 2.68 and 2.06 vs. 1.67 for National Cholesterol Education Program definition and 1.35 for other definitions; p = 0.005). The association remained after adjusting for traditional cardiovascular risk factors (RR 1.54, 95% CI 1.32 to 1.79).Conclusions The best available evidence suggests that people with MetSyn are at increased risk of cardiovascular events. These results can help clinicians counsel patients to consider lifestyle interventions, and should fuel research of other preventive interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2006.09.032

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MetS is a clinical entity associated with an increased risk of ASCVD or death, even after controlling for its component risk factors (risk ratio: 1.54; 95% confidence interval: 1.32 to 1.79).

    “It is imperative to recognize that MetS is not just a repackaging of its individual risk components, but, as demonstrated in at least 1 analysis, is a clinical entity associated with an increased risk of ASCVD or death, even after controlling for its component risk factors (risk ratio: 1.54; 95% confidence interval: 1.32 to 1.79) (39).”

    From The CardioMetabolic Health Alliance (2015) · cites this paper as [39]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observa- tional studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000;283:2008 -12.

Cited by

Sorted by citations

Authors
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M.
Affiliations
Mayo Clinic (US)
Corresponding author
Gami, Apoor S.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2007-01
Volume
49
Issue
4
Pages
403-414
ISSN
0735-1097 (ISSN-L)
OpenAlex
W74340591
Cited by
1,888
References
67
Citations by year
2026: 31 · 2025: 38 · 2024: 70 · 2023: 58 · 2022: 76 · 2021: 91 · 2020: 87 · 2019: 99 · 2018: 103 · 2017: 84 · 2016: 113 · 2015: 125 · 2014: 131 · 2013: 140 · 2012: 122
FWCI
91.62
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
metabolic syndrome, cardiovascular events, cardiovascular mortality, cardiovascular risk, sex differences, metabolic syndrome definitions, traditional cardiovascular risk factors, lifestyle intervention
MeSH terms
Cardiovascular Diseases, Humans, Longitudinal Studies, Risk Factors, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review